Article
MRI-based Prognostic Model in Early-Stage HR+/HER2- Breast Cancer
2026-06-28
Abstract excerpt
<title>Abstract</title> <p>Current genomic assays provide prognostic information and guide chemotherapy decisions in early-stage hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2−) breast cancer, but limited tissue sampling may incompletely capture tumor heterogeneity. We developed and validated an image-based artificial intelligence (AI) model integrating dynamic contrast-enha...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dc08554c-d454-5614-84fc-263559476453
- DOI
- 10.21203/rs.3.rs-9772767/v1
